Skip to main content
Premium Trial:

Request an Annual Quote

MolecularWare Lands $2.5M in Funding

NEW YORK, August 1 – The bioinformatics company MolecularWare has received $2.5 million in first-round funding, the company announced Wednesday.

The Cambridge, Mass.-based company said it would use the money to continue to commercialize its DigitalGenome suite of high throughput analysis software. 

The “Series A” funding came from several sources including lead investors Aspen Investment Group and KnowledgeCube Group. 

“This capital enables the acceleration of product enhancement and development, along with the acquisition of additional customers and key personnel,” Richard  Kivel, CEO of MolecularWare, said in a statement.

MolecularWare customers include the Whitehead Institute, Riken University for Genome Research in Japan, and the University of Tskuba in Japan. MolecularWare was founded in 1999.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.